The FDA continues to grant emergency use authorization to two monoclonal antibody treatments

for non-hospitalized adults and children over age 12 with mild to moderate COVID-19
symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. The
treatments are: a combination of casirivimab and imdevimab, made by Regeneron; and a
combination of bamlanivimab and etesevimab, made by Eli Lilly. (In April 2021, prior approval
of the solo use of bamlanivmab to treat COVID-19 was withdrawn because of new data showing
limited effectiveness.)

In these patients, the approved treatment may reduce the risk of hospitalization and emergency
room visits. These therapies must be given intravenously (by IV), which means a scheduling a
visit in a clinic or hospital soon after developing symptoms.
If you are recovering at home, these measures can help reduce symptoms:
 While you don't need to stay in bed, you should get plenty of rest.
 Stay well hydrated.
 To reduce fever and ease aches and pains, take acetaminophen. Be sure to follow
directions. If you are taking any combination cold or flu medicine, keep track of all the
ingredients and the doses. For acetaminophen, the total daily dose from all products
should not exceed 3,000 milligrams.
Theme : Covid -19
Topic : Treatments for Covid-19
Judul : Therapy used in covid 19 sufferers

Paragraph 1 (Introduction)
Main thoughts : Developing severe COVID-19 or being hospitalized
Paragraph 2
Main thoughts : These therapies must be given intravenously (by IV)
 Covid-19 recovery tips at home